Want to join the conversation?
$LH's LabCorp Diagnostics is expected to grow 4.5-5.5% in 2015, after the impact of about 90 basis points of negative currency. This is an increase from prior guidance of 3.5-5.5%, mainly due to continued strong organic growth. Covance Drug Development revenue is expected to be in the range of -0.5% to 0.5% versus 2014.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.